Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) FCF Margin (2024 - 2026)

Updated

Genmab A's FCF Margin came in at 4.42% for the quarter ended Jun 30, 2026, up 4.08 percentage points from the prior quarter.

Analysis

Genmab A (GMAB) FCF Margin (2024 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Genmab A reported FCF Margin of 21.94%; for the year ended Dec 31, 2025, it came in at 30.89%, down 4.33 percentage points from the prior year.

  • Going back by year, FCF Margin was 35.21% in the year ended Dec 31, 2024 (-7.38 pp) and 42.59% in the year ended Dec 31, 2023.
  • The five-year range for quarterly FCF Margin is 0.33% (the quarter ended Mar 31, 2026) to 52.45% (the quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 33.69%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 25.03%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 41.97%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 30.51%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 38.60%
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 35.25%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 57.81%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 28.96%
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 43.81%
Jun 30, 2026 4.42%
Mar 31, 2026 0.33%
Sep 30, 2025 52.45%
Mar 31, 2025 40.14%
Sep 30, 2024 36.64%
Mar 31, 2024 36.32%
API Access

Genmab A FCF Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=fcf-margin&ticker=GMAB&period=max&api_key=YOUR_API_KEY